Sorafenib targets the mitochondrial electron transport chain complexes and ATP synthase to activate the PINK1–Parkin pathway and modulate cellular drug response
2017 ◽
Vol 292
(36)
◽
pp. 15105-15120
◽
2004 ◽
Vol 148
(1-2)
◽
pp. 11-18
◽
2011 ◽
Vol 117
(2)
◽
pp. 209-220
◽
2008 ◽
Vol 45
(6)
◽
pp. 826-838
◽
2008 ◽
Vol 44
(10)
◽
pp. 1795-1805
◽
2013 ◽
Vol 14
(3)
◽
pp. 377-389
◽